Business Wire

Intersolar Europe: Agrivoltaics – Harvesting Solar Power

Share

The world population is growing, as is the demand for food. To tackle the climate crisis, the world needs both agricultural land and surfaces for the deployment of photovoltaics (PV). In line with the zeitgeist, agricultural PV brings together both worlds: agriculture and renewable power generation. Solar modules built over fields can transport us into the new energy world faster, all the while protecting important agricultural yields. This is why Intersolar Europe – The world’s leading exhibition for the solar industry – will be focusing on the topic. Together with the French-German Office for Energy Transition (DFBEW), Intersolar Europe will be presenting new business models and best practices from France and Germany. Agricultural PV is also on the agenda of the Intersolar Europe Conference. Intersolar Europe will be held as part of The smarter E Europe, the continent’s largest platform for the energy industry, from June 14 to 16, 2023 in Munich.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230427005413/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Trend topic Agrivoltaics will be presented at Intersolar Europe 2023 in Munich, Germany. (Photo: Solar Promotion GmbH)

Agrivoltaics is currently trending. Agrivoltaics projects are demonstrating how the generation of solar power and agriculture can go hand in hand and benefit from each other and how the conflict over available surfaces can be cleverly solved.

Renewable electricity for decentralized self-consumption is a great opportunity for agricultural operations adding solar installations to their assets. It allows them to use the renewable power generated on their land and reduce their bills for grid-supplied electricity. If they have excess electricity, they can sell it, which provides an additional source of income. What’s more, agricultural PV installations can boost resilience and increase the yield of agricultural operations because solar modules offer protection against heavy rain, hail or drought for fruit and special crops.

Europe recognizes potential

In many European countries, more and more farmers and political decision-makers are recognizing the potential of agricultural PV. Italy, for instance, recently passed new regulations that determine which agricultural PV installations are eligible for funding from a government incentive program with a scope of 1.1 billion euros, giving a boost to innovative agricultural PV installations. While Germany is testing agricultural PV in combination with the cultivation of apples, for example, in Gelsdorf in Rhineland Palatinate, France has started installing solar modules over rows of vines.

With tractor and tracker – trend towards dual use

Covering crops with raised solar modules – as French winegrowers are doing now – is particularly interesting because it is favorable for winegrowing, as well as for fruit, berries or herbs, and any plants that prefer partial shade. Furthermore, solar roofs can replace conventional hail netting or polytunnels, and they protect the crops from drying out.

Integrating solar installations into agriculture opens up many areas of application. Free-standing solar installations on fields and meadows can also be equipped with trackers that follow the course of the sun, which increases the yield compared with conventional, fixed modules, by around 20 percent. The solar panels can also be moved out of the way of any working agricultural machinery.

Agri PV: Hot topic at Intersolar Europe

To learn all there is to know about solar power generation in agriculture, join us at Intersolar Europe. The session “Agricultural PV in France and Germany: Potential, Business Models and Best Practice” (Agri-PV in Deutschland und Frankreich: Potenziale, Geschäftsmodelle und Best Practices) on June 15 at 3:20pm CEST at the Intersolar Forum will be presenting an extensive overview of solutions and applications that already work. An even more hands-on experience will be offered by many exhibitors, such as BayWa r.e. AG, Fraunhofer Institute for Solar Energy Systems (ISE), Next2Sun GmbH, Goldbeck Solar GmbH, SunFarming GmbH and many more. The program of the Intersolar Europe Conference will be looking into agricultural PV one day before the start of the exhibition itself. Experts will be discussing the potential of solar power in agriculture.

Intersolar Europe will be held from June 14–16, 2023 as part of The smarter E Europe 2023 at Messe München. Over 85,000 visitors from all corners of the globe are expected to attend. More than 2,200 exhibitors across 17 exhibition halls covering 180,000 square meters will be waiting for them.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Peggy Zilay
Spokesperson
The smarter E Europe
+49 7231 58598-240
zilay@solarpromotion.com

Juliane Heermeier
Account Manager
+49 151 41482446
juliane.heermeier@fischerappelt.de

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release

Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release

Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r

Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr

Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 13:31:00 EET | Press release

The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p

Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 01:49:00 EET | Press release

Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive Officer, Lattice Semiconductor. The annual GSA Awards celebrate the accomplishments of the semiconductor indu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye